314 related articles for article (PubMed ID: 19241507)
1. Neuroendocrine tumors: characterization with contrast-enhanced ultrasonography.
Dörffel Y; Wermke W
Ultraschall Med; 2008 Oct; 29(5):506-14. PubMed ID: 19241507
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.
Massironi S; Conte D; Sciola V; Pirola L; Paggi S; Fraquelli M; Ciafardini C; Spampatti MP; Peracchi M
Dig Liver Dis; 2010 Sep; 42(9):635-41. PubMed ID: 20172770
[TBL] [Abstract][Full Text] [Related]
3. Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors.
Del Prete M; Di Sarno A; Modica R; Lassandro F; Giorgio A; Bianco A; Muto M; Gasperi M; Del Prete F; Colao A; Montesarchio V; Faggiano A;
J Endocrinol Invest; 2017 Dec; 40(12):1373-1380. PubMed ID: 28667452
[TBL] [Abstract][Full Text] [Related]
4. Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features?
Gulpinar B; Peker E; Kul M; Elhan AH; Haliloglu N
Abdom Radiol (NY); 2019 Jun; 44(6):2147-2155. PubMed ID: 30863999
[TBL] [Abstract][Full Text] [Related]
5. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
Oldenburg A; Albrecht T
Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
[TBL] [Abstract][Full Text] [Related]
6. Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography.
Mörk H; Ignee A; Schuessler G; Ott M; Dietrich CF
Scand J Gastroenterol; 2007 May; 42(5):652-62. PubMed ID: 17454888
[TBL] [Abstract][Full Text] [Related]
7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound features of histologically proven small (≤20 mm) liver metastases.
Dong Y; Zhang XL; Mao F; Huang BJ; Si Q; Wang WP
Scand J Gastroenterol; 2017 Jan; 52(1):23-28. PubMed ID: 27577113
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced ultrasonography in patients with colorectal liver metastases after chemotherapy.
Konopke R; Bunk A; Kersting S
Ultraschall Med; 2008 Sep; 29 Suppl 4():S203-9. PubMed ID: 18833498
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
[TBL] [Abstract][Full Text] [Related]
12. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
13. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.
Lee J; Jeong WK; Lim HK; Kim AY
J Ultrasound Med; 2018 Jun; 37(6):1473-1480. PubMed ID: 29159819
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced ultrasound (CEUS) in the evaluation of liver metastases.
Dănilă M; Popescu A; Sirli R; Sporea I; Martie A; Sendroiu M
Med Ultrason; 2010 Sep; 12(3):233-7. PubMed ID: 21203602
[TBL] [Abstract][Full Text] [Related]
15. Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas.
Li R; Zhang X; Hua X; Cai P; Zhong H; Guo Y; Ding S; Yan X
Abdom Imaging; 2010 Dec; 35(6):676-82. PubMed ID: 20020286
[TBL] [Abstract][Full Text] [Related]
16. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
17. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound.
Rickes S; Ocran KW; Gerstenhauer G; Neye H; Wermke W
Dig Dis; 2004; 22(1):81-6. PubMed ID: 15292699
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced sonography of nonfunctioning pancreatic neuroendocrine tumors.
Malagò R; D'Onofrio M; Zamboni GA; Faccioli N; Falconi M; Boninsegna L; Mucelli RP
AJR Am J Roentgenol; 2009 Feb; 192(2):424-30. PubMed ID: 19155405
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound pattern of splenic metastases - a retrospective study in 32 patients.
Neesse A; Huth J; Kunsch S; Michl P; Bert T; Tebbe JJ; Gress TM; Görg C
Ultraschall Med; 2010 Jun; 31(3):264-9. PubMed ID: 19899027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
